baber/WOPTO huggingface dataset:
Patent DE-69409818-D1 (DE)
Inventor: ATHERTON JOHN
IPC: C10M163/00
Filed: 1994-09-09
Granted: 1998-05-28
Abstract: PCT No. PCT/GB94/01974 Sec. 371 Date Jul. 29, 1996 Sec. 102(e) Date Jul. 29, 1996 PCT Filed Sep. 9, 1994 PCT Pub. No. WO95/07966 PCT Pub. Date Mar. 23, 1995A lubricant composition e.g. for engine oils comprises (i) a base oil, (ii) an antiwear additive combination comprising (a) an organo-molybdenum compound and (b) an asoless organo-phospoorus compound, and (iii) an antioxidant additive combination comprising (d) an aminic antioxidant and (e) a phenolic antioxidant, the weight ratio of aminic antioxidant to phenolic antioxidant being greater than 1:1, preferably from 1.5:1 to 20:1. The antiwear additive combination (ii) may further comprise (c) a zinc thiophosphate compound selected from zinc dialkyldithiophosphate, zinc diaryldithiophosphate and zinc alkylaryldithiophosphate and zinc arylalkyldithiopoosphate and mixtures thereof.
Patent DE-69409961-D1 (DE)
Inventor: MATTHEWS DONALD
IPC: A61K31/435
Filed: 1994-08-19
Granted: 1998-06-04
Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
Patent DE-69416458-D1 (DE)
Inventor: HILTUNEN MATTI
IPC: F28C3/16
Filed: 1994-06-23
Granted: 1999-03-25
Abstract: A method and apparatus for cooling hot gas in a reactor (10) in which the lower section of the reactor is provided with an inlet (16) for hot gas and a chamber (12) encompassing a bubbling fluidized bed (14), the middle section is provided with a riser (22), and the upper section with a gas outlet (30), and the reactor has heat transfer surfaces (24, 44, 46) for recovering heat from solid particles. The riser is defined by vertical walls (24), which are arranged above the bubbling fluidized bed so that they divide the fluidized bed into an outer (12') and inner (12'') part. From the inner part (12'') of the fluidized bed (14) solid particles are supplied to the hot inlet gas for cooling thereof. The gas containing solid particles is conveyed through the riser (22) into the upper section of the reactor, where solid particles are separated from the gas in a particle separator (28) and returned to the fluidized bed into the outer part (12') thereof. <IMAGE>
Patent DE-69427573-D1 (DE)
Inventor: KIMURA MOTOKO
IPC: A61K31/57
Filed: 1994-12-23
Granted: 2001-08-02
Abstract: An ophthalmic suspension comprising diflupredonate as an active ingredient. The ophthalmic suspension of the present invention shows superior antiinflammatory action and antiallergic action by local administration. Accordingly, the suspension of the present invention is useful for the treatment and prevention of disorders of the eye, such as allergic conjunctivitis, vernal conjunctivitis, blepharitis marginalis, catarrhal conjunctivitis and uveitis.
Patent DE-69519480-D1 (DE)
Inventor: DORRICOTT JAMES DEREK
IPC: B22D41/50
Filed: 1995-04-25
Granted: 2000-12-28
Abstract: A submerged entry nozzle for flowing liquid metal therethrough includes a vertically disposed entrance pipe section having a generally axial symmetry and a first cross-sectional flow area. A transition area having the first cross-sectional flow area with two or more front walls and two or more side walls reduces the thickness of the first cross-sectional area by providing a convergent angle of the front walls and increases the width of the first cross-sectional area by providing a divergent angle of the side walls thereby producing a second cross-sectional area of the transition area which is generally elongated and of planar symmetry. The flow of liquid metal from the transition area is divided into two streams angularly deflected from the vertical in opposite directions.
Patent DE-69527304-D1 (DE)
Inventor: TSUDA SHIRO
IPC: C10M125/10
Filed: 1995-12-15
Granted: 2002-08-08
Abstract: The present invention relates to a ferrofluid composition having improved oxidation resistance, which contains a carrier liquid, magnetic particles in a stable colloidal suspension, and from about 5% to about 50% by weight of an antioxidant.
Patent DE-69530117-D1 (DE)
Inventor: DEVRIES F
IPC: F04B49/06
Filed: 1995-07-05
Granted: 2003-04-30
Abstract: An exhalation valve for controlling the expiratory gas flow from a mammalian patient, said exhalation valve comprising:a housing defining an expiratory gas flow passageway therethrough;a valve seat formed within said expiratory gas flow passageway;an annular diaphragm movably disposed within said gas flow passageway, in juxtaposition to said valve seat, said diaphragm being variably movable back and forth to various positions between and including:i) a fully closed position wherein said diaphragm is firmly seated against said valve seat to prevent gas from flowing through said passageway; andii) a fully open position wherein said diaphragm is retracted away from said annular valve seat so as to permit substantially unrestricted flow of expiratory gas through said pathway;an elongate actuation shaft having a proximal end and a distal end, the distal end of said actuation shaft being contactable with said diaphragm, and said actuation shaft being axially moveable back and forth to control the positioning of said diaphragm between said fully closed and said fully open positions;an electrical induction coil linked to said actuation shaft such that a decrease in the current passing into said induction coil will cause said shaft to advance in the distal direction and an increase in the current passing into said induction coil will cause said shaft to retract in the proximal direction;means for determining airway pressure;a microprocessor controller connected to said means for determining airway pressure, said controller being provided with a positive expiratory pressure setting, and said controller being connected to said induction coil and adapted to emit control signals to said induction coil to control the movement of said actuation shaft in response to the current airway pressure, thereby maintaining the present amount of positive expiratory pressure;a radio frequency transponder database containing flow characterisation data for the means for determining the flow rate of expiratory gas passing out of said exhalation valve;said controller being further connected to said means for determining the flow rate of expiratory gas passing out of said exhalation valve and being equipped to receive radio frequency input of the characterisation data contained in the radio frequency transponder database, and to utilise such data to determine the instant flow rate of expiratory gas passing out of said exhalation valve.
Patent DE-69532077-D1 (DE)
Inventor: CAI XIONG
IPC: C07D471/04
Filed: 1995-06-27
Granted: 2003-12-11
Abstract: Tetrahydrofurans, tetrahydrothiophenes, pyrrolidines and cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i.e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase. It has been determined that 5-lipoxygenase activity, oral availability, and stability in vivo (for example, glucuronidation rate) can vary significantly among the optical isomers of the disclosed compounds.
Patent DE-69533806-D1 (DE)
Inventor: GREGORY KENTON W
IPC: A61L27/00
Filed: 1995-04-04
Granted: 2004-12-30
Abstract: The present invention relates to an elastin-based biomaterial and to a method of using same to effect tissue repair or replacement. The invention further relates to a method of securing the biomaterial to existing tissue.
Patent DE-69600988-D1 (DE)
Inventor: LUCIANI LUCIANO DR
IPC: C08F4/646
Filed: 1996-09-20
Granted: 1998-12-24
Abstract: Procedure for the preparation of a solid catalyst component which is active in the polymerization of olefins, comprising the steps: a) contacting a silylated silica support with a solution of Mg-halide or Mg-alkyl-halide or a mixture of both and Ti-alkoxide or Ti-halogen-alkoxide or a mixture of both, optionally in the presence of Ti-tetrahalide, b) contacting the catalyst-precursor obtained in (a) with Mg-alkyl or Mg-alkyl-halide or a mixture of both, optionally in presence of Lewis base, c) halogenating the catalyst-precursor obtained in (b) by contact of said activated support with halogenating agents, d) titanating the catalyst-precursor obtained in (c) with Ti-tetrahalide in the presence of electron-donors, e) recovering the solid catalyst-component from the reaction products of step (d). The catalyst component, which is obtained according to the above procedure, may also be used together with Al-trialkyl or Al-alkyl-halides and a Lewis base, as a catalyst for the polymerization of olefins.
Patent DE-69606344-D1 (DE)
Inventor: HAYAKAWA YOSHIYUKI
IPC: E04G17/04
Filed: 1996-04-10
Granted: 2000-03-02
Abstract: A concrete molding form member connector comprises a first holding portion (3) having a linearly extending first holding surface (3a) of a prescribed length, a cylindrical insertional shaft portion (2), having a central axis being perpendicular to the first holding surface (3a), which is provided in the vicinity of a first end of the first holding surface (3a), and a second holding portion (4), having a second holding surface (4a) being opposed to the first holding surface (3a) in a parallel manner at a prescribed space in a region close to a second end of the first holding surface (3a), which is continuous with the first holding portion (3) on the second end of the first holding surface (3a) so that its free end is positioned at a prescribed space with respect to the insertional shaft portion (3). The insertional shaft portion (2) is inserted in through holes which are provided in overlapping side plate portions of adjacent form members so that the connector is rotated about the same, whereby the side plate portions of the adjacent form members are held between the first holding surface (3a) and the second holding surface (4a). Consequently, a lightweight concrete molding form member connector having excellent workability, which can be provided at a relatively low cost, is provided. <IMAGE>
Patent DE-69619382-D1 (DE)
Inventor: AKHAVAN-TAFTI HASHEM
IPC: C07F7/18
Filed: 1996-06-19
Granted: 2002-03-28
Abstract: PCT No. PCT/US96/09248 Sec. 371 Date Dec. 22, 1997 Sec. 102(e) Date Dec. 22, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00869 PCT Pub. Date Jan. 9, 1997A process for producing a stable triggerable dioxetane comprising; (a) reacting a vinyl sulfide compound containing a sulfur-substituent SR4, wherein R4 is an organic group containing 1 to 20 carbon atoms and optionally heteroatoms, with oxygen and light in the presence of a photosensitizer to form an intermediate sulfur-substituted dioxetane compound; and (b) reacting the sulfur-substituted dioxetane compound with an electrophilic compound E-Y and a hydroxylic compound R5OH selected from the group consisting of alcohols, phenols and carboxylic acids or their salts and containing an OR5 group to replace the SR4 group of the dioxetane with the OR5 group.
Patent DE-69619650-D1 (DE)
Inventor: STAHL AKE
IPC: A23L1/0522
Filed: 1996-07-01
Granted: 2002-04-11
Abstract: PCT No. PCT/SE96/00872 Sec. 371 Date Feb. 24, 1997 Sec. 102(e) Date Feb. 24, 1997 PCT Filed Jul. 1, 1996 PCT Pub. No. WO97/03573 PCT Pub. Date Feb. 6, 1997The use of amylopectin-type starch obtained from potato that has been modified by genetic engineering to suppress the formation of amylose-type starch as a filling agent in the preservation of food-stuff, is described.
Patent DE-69629378-D1 (DE)
Inventor: WILLIAMS E
IPC: C08L53/02
Filed: 1996-05-21
Granted: 2003-09-11
Abstract: There is provided a composition comprising a unique polymeric compound that provides a soft, flexible product. There is also provided a unique polymeric tampon applicator that is soft and flexible. When used as a tampon applicator barrel, the barrel is more comfortable and has improved ease of insertion. The polymeric compound primarily comprises a thermoplastic resin and a block copolymer that exhibit unique load, energy and modulus of elasticity properties. The polymeric compound should also include a plasticizer and a compatibilizer/flow modifier, and may include a slip/mold release agent, an antioxidant, and even a pigment. There is also provided a method for making the polymeric compound that will be formed into a product, such as an applicator or applicator barrel in which all of the above ingredients, except for the thermoplastic resin, are combined and formed into soft pellets. The soft resin pellets are then dry blended with pellets of the thermoplastic resin. The mixture of the thermoplastic resin pellets and the soft resin pellets are then melted and injection molded into the desired shape. There is thus provided a method of making a soft, polymeric tampon applicator or tampon applicator barrel.
Patent DE-69707919-D1 (DE)
Inventor: ALBERT LUC
IPC: C22C11/06
Filed: 1997-02-13
Granted: 2001-12-06
Abstract: A lead alloy for battery grids is disclosed. The lead alloy contains calcium with a relative concentration by weight of between 0.05% and 0.12%; tin with a relative concentration by weight of less than 3%; aluminum with a relative concentration by weight of between 0.002% and 0.04%; and barium comprising a relative concentration by weight of less than 0.02%.
Patent DE-69708466-D1 (DE)
Inventor: PERRET MICHEL
IPC: H01H33/915
Filed: 1997-01-16
Granted: 2002-01-10
Abstract: The switching circuit includes the upper nozzle (6a) which in the closed position contacts a tube (16) with inner nozzle (16A). The tube is held in a piston (9) which slides in a circular section (12). The circuit is held in a sealed outer and filled with inert gas. The sliding section has an upper hour glass extension (20) attached to its upper end and held in position on isolated sliding sections (23) around an upper fixed piston holding the upper nozzle. The outer arc section also contacts a permanent outer connection (2). The mobile section is moved downwards to break the circuit, losing contact with the tubular section, with the hour glass section providing arcing returns.
Patent DE-69710087-D1 (DE)
Inventor: EUVERINK JAN
IPC: A23L29/20
Filed: 1997-10-06
Granted: 2002-03-14
Abstract: The invention relates to the use of modified starch obtainable by treating amylose containing starch in aqueous medium with an enzyme from the group of the alpha-1,4-alpha-1,4-glucosyl transferases (EC 2.4.1.25) or an enzyme the activity of which corresponds to that of enzymes from the group just mentioned, as an agent for forming a thermoreversible gel. The invention also relates to products in the form of a thermoreversible gel having as gel-forming substance a modified starch as defined. The invention further relates to the use of a modified starch as defined in the form of an aqueous solution.
Patent DE-69723864-D1 (DE)
Title: Ethyliden-derivate tricyclyscher carbapenems
Inventor: COPAR ANTON
IPC: C07D495/14
Filed: 1997-12-18
Granted: 2003-09-04
Abstract: Disclosed are novel ethylidene derivatives of tricyclic carbapenems of the formula Iwherein the ring marked C and X have the meaning as in the description, in the form of pure diastereoisomers and in the form of pure geometric isomers. Novel ethylidene derivatives of tricyclic carbapenems of the formula I are used as inhibitors of the action of the enzyme beta-lactamase and/or as antibiotics in human and veterinary medicine. Also disclosed are pharmaceutical formulations for the treatment of bacterial infections of human and animal organisms comprising as an active ingredient a therapeutically effective amount of an ethylidene derivative of tricyclic carbapenems of the formula I in the form of an acid, a pharmaceutically acceptable salt or ester thereof and optionally in a combination with a beta-lactam antibiotic, and usual pharmaceutically acceptable carriers and auxiliary substances.Also disclosed is a process for the preparation of novel ethylidene derivatives of tricyclic carbapenems of the formula I.
Patent DE-69725179-D1 (DE)
Inventor: DIMCOVSKI ZLATIMIR
IPC: G01T1/22
Filed: 1997-08-11
Granted: 2003-10-30
Abstract: The invention concerns a method, a sensor and a radiographic imaging system in real time for discriminating the low energy ionizing radiation, corresponding at least partially to dispersion radiation, thereby eliminating their contribution in the sensed image, so as to increase the contrast, for relatively reduced amounts of incident radiation. In the figure is presented a radiographic system more particularly designed for radiotherapy, basically consisting of an accelerator (1) emitting a collimated beam (3) of photons and in particular of X-rays towards a patient lying down (2). The patient is positioned so as to enable the best possible localization not only of the collimated gamma or X-ray beam impact but its depth as well and the localization of the portion where the major part of the dose is to be delivered. For this purpose, the installation comprises a sensor (4), located subjacent which interprets the sensed signals by means of a microcomputer (5), after interfacing, so as to provide in real time a corresponding image, which can be immediately interpreted.
Patent DE-69805295-D1 (DE)
Inventor: EKBLOM JARI
IPC: C07J9/00
Filed: 1998-02-25
Granted: 2002-06-13
Abstract: The invention relates to a process for the preparation of stanol esters by hydrogenating a sterol blend in a hydrogenation solvent and at an elevated temperature in the presence of a hydrogenation catalyst, by removing the hydrogenation catalyst from the obtained hot reaction solution, by transesterifying the intermediate stanol blend with a fatty acid methyl ester at an elevated temperature and in the presence of a transesterification catalyst, and by finally purifying the stanol ester blend thus obtained. According to the invention, the intermediate stanol blend is neither crystallized nor removed from the reaction solution but the hydrogenation solvent is replaced therein at least in part by a transesterification reagent. Alternatively, the hydrogenation solvent may also be used as the transesterification solvent, and preferably also as the transesterification reagent.
Patent DE-69807345-D1 (DE)
Inventor: KOUTONEN PAULI
IPC: B65H18/08
Filed: 1998-06-01
Granted: 2002-09-26
Abstract: The invention concerns a method in winding of a web in a centre-drive winder, wherein the roll that is being formed is loaded and/or supported by means of a rider roll unit (40) whose position can be varied and which consists of at least two rolls (42). In the method, the force that is applied by the rider roll unit (40) to the roll face in the radial direction and/or the distribution of said force between the rolls (42) in the rider roll unit (40) is/are measured by means of a detector of detectors (31 . . . 36) directly connected with the winding head of the rider roll unit (40). The nip force of the rolls (42) in the rider roll unit (40) and/or the distribution of said nip force is/are regulated on the basis of the measurement signal given by the detectors.
Patent DE-69821640-D1 (DE)
Inventor: LUNDBORG GOERAN
IPC: A61F2/50
Filed: 1998-04-29
Granted: 2004-03-18
Abstract: The artificial sensibility device has a left sensor applied to a left finger, a middle sensor applied to a middle finger and a right sensor applied to a right finger of a hand. The sensors are connected to an amplifier unit that is connected to a headphone unit with a left speaker and a right speaker. The left finger is moved against a surface to activate the left sensor to send a first activation signal to the amplifier unit that sends a first sound signal only to the left speaker but nothing to the right speaker so the user knows the left finger is moved. The right finger is moved against the surface so that the right sensor sends a second sound signal only to the right speaker but nothing to the left speaker.
Patent DE-69822665-D1 (DE)
Inventor: CROW JAMES W
IPC: A61P7/02
Filed: 1998-11-13
Granted: 2004-04-29
Abstract: An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9- alpha -methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene)-13,14-dihydro-prostaglandin F1.
Patent DE-69831340-D1 (DE)
Inventor: PAWELKA EDUARD-FRANZ
IPC: B41J25/34
Filed: 1998-02-06
Granted: 2005-09-29
Abstract: The present invention relates to a thermal printer (120) for housing a print module (128, 130, 134). The printer (120) comprises a frame, with a swing arm (126) connected to this. This swing arm (126) is pivotable between a printing and non-printing position. The print module (128, 130, 134, 132) includes a carriage (128) including fastening structure (126) for detachably fastening the carriage (128) to the swing arm (126). When the swing arm (126) is in the printing position, the carriage (128) is aligned so that the print module (128, 130, 134) is adapted to print a substrate. There is provided a resilient structure (158) to bias the carriage (128) toward the printing position. <IMAGE>
Patent DE-69838768-D1 (DE)
Inventor: HUISMAN GJALT W
IPC: C12N9/02
Filed: 1998-09-18
Granted: 2008-01-03
Abstract: The gene encoding a 4-hydroxybutyryl-Co A transferase has been isolated from bacteria and integrated into the genome of bacteria also expressing a polyhydroxyalkanoate synthase, to yield an improved production process for 4HB-containing polyhydroxyalkanoates using transgenic organisms, including both bacteria and plants. The new pathways provide means for producing 4HB containing PHAs from cheap carbon sources such as sugars and fatty acids, in high yields, which are stable. Useful strains are obtaining by screening strains having integrated into their genomes a gene encoding a 4HB-CoA transferase and/or PHA synthase, for polymer production. Processes for polymer production use recombinant systems that can utilize cheap substrates. Systems are provided which can utilize amino acid degradation pathways, α-ketoglutarate, or succinate as substrate.
Patent DE-69841014-D1 (DE)
Inventor: ZUCKERMANN RONALD
IPC: B01J19/00
Filed: 1998-04-28
Granted: 2009-09-10
Abstract: An apparatus is provided for conducting solid phase oligomer synthesis. The apparatus includes a reaction vessel in which a solid phase support is contained. The reaction vessel has a top opening through which gases and solvents can be delivered by way of a series of conduits and valves. The reaction vessel is interconnected through a bottom opening therein and through a series of conduits and valves with a vessel or series of vessels containing a reagent or series of reagents, respectively, required for the synthetic reaction. The reagent vessel serves a both a source of reagent delivered to the reaction vessel and as a repository for unused reagent returned thereto from the reaction vessel. Reagent delivery and mixing is gas-driven using an associated source of an inert gas.